Dow Down 0.56% Nasdaq Down 0.79%

Alkermes plc (ALKS)

-NasdaqGS
37.62 Down 1.58(4.03%) May 4, 4:00PM EDT
Prev Close:39.20
Open:38.60
Bid:N/A
Ask:48.66 x 100
1y Target Est:44.40
Beta:2.10494
Earnings Date:Jul 28 - Aug 1 (Est.)
Day's Range:37.33 - 38.80
52wk Range:27.14 - 80.71
Volume:1,059,441
Avg Vol (3m):1,615,530
Market Cap:5.69B
P/E (ttm):N/A
EPS (ttm):-1.52
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ALKSDown 4.03%5.69B
LLYDown 1.81%79.59B
GSKDown 1.83%102.49B
ABTDown 1.17%55.99B

Key Statistics

Forward P/E (1 yr):163.57
P/S (ttm):9.40
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.30
Quarterly EPS Est (Jun-16) :-0.10
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):5.66

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products that are designed to address unmet medical needs of patients in various therapeutic areas worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback